Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsAdam Mayerson, MD, FACE
Associate Clinical ProfessorAbout
Research
Publications
2023
Improved extremity tissue oxygenation with short-term exposure to textiles embedded with far infrared light emitting thermoactive particles in patients with diabetes mellitus
Athonvarangkul D, Wang K, Deng Y, Inzucchi S, Mayerson A. Improved extremity tissue oxygenation with short-term exposure to textiles embedded with far infrared light emitting thermoactive particles in patients with diabetes mellitus. Diabetes And Vascular Disease Research 2023, 20: 14791641231170282. PMID: 37073436, PMCID: PMC10123901, DOI: 10.1177/14791641231170282.Peer-Reviewed Original Research
2008
Development of Thyroid Storm After Surgical Resection of A Thyrotropin-Secreting Pituitary Adenoma
Page KA, Roehmholdt BF, Jablonski M, Mayerson AB. Development of Thyroid Storm After Surgical Resection of A Thyrotropin-Secreting Pituitary Adenoma. Endocrine Practice 2008, 14: 732-737. PMID: 18996794, DOI: 10.4158/ep.14.6.732.Peer-Reviewed Case Reports and Technical NotesConceptsPostoperative thyroid stormThyroid stormSurgical resectionSuprasellar tumorsPituitary adenomasThyrotropin-secreting pituitary adenomaBeta-adrenergic blocking agentsLarge suprasellar tumorsTSH-secreting adenomaThyroid-stimulating hormoneLaboratory evaluationThyroid hormone levelsPostoperative thyrotoxicosisHormonal abnormalitiesHormonal evaluationPituitary massYounger patientsInitial presentationMale patientsSevere headachePathologic findingsCase reportHormone levelsBlocking agentSurgical procedures
2007
Levemir® Early Clinical Experience Case Series
Mayerson AB. Levemir® Early Clinical Experience Case Series. Endocrinology And Metabolism Clinics Of North America 2007, 36: 45-52. PMID: 17881331, DOI: 10.1016/s0889-8529(07)80007-7.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsInsulin detemirCase seriesDiscontinuation of treatmentMean weight lossLarge observational studiesType 2 diabetesDaily regimenFinal followTreatment discontinuationGlycemic controlTreatment initiationHypoglycemic episodesA1C valuesCase reportThird followObservational studyDetemirMean decreasePatientsSpecial interventionDoctor's officeWeight lossObservation periodDiscontinuationRegimenA Woman With Chronic Urticaria and Graves Disease
Goldberg P, Mayerson A. A Woman With Chronic Urticaria and Graves Disease. The Endocrinologist 2007, 17: 217-220. DOI: 10.1097/ten.0b013e3181237999.Peer-Reviewed Case Reports and Technical NotesChronic urticariaGraves' diseaseElevated thyroid peroxidase antibodiesNormal thyroid function testsNew-onset hyperthyroidismNear-total thyroidectomyThyroid peroxidase antibodiesDay of surgeryThyroid-stimulating immunoglobulinThyroid function testsAutoimmune thyroid diseaseMU/LSeverity of urticariaElevated thyroxine levelsInitial laboratory evaluationNuclear imaging studiesDiffuse myalgiaStandard therapyThyroid autoimmunityClinical courseMedical therapyPeroxidase antibodiesTherapeutic trialsThyrotropin levelsFunction tests
2005
Tumor‐to‐tumor metastasis to a thyroid follicular adenoma as the initial presentation of a colonic adenocarcinoma
Fadare O, Parkash V, Fiedler PN, Mayerson AB, Asiyanbola B. Tumor‐to‐tumor metastasis to a thyroid follicular adenoma as the initial presentation of a colonic adenocarcinoma. Pathology International 2005, 55: 574-579. PMID: 16143033, DOI: 10.1111/j.1440-1827.2005.01871.x.Peer-Reviewed Case Reports and Technical NotesConceptsThyroid neoplasmsMetastatic depositsDonor tumorTumor metastasisColonic adenocarcinoma metastaticSigmoid colon tumorInitial clinical manifestationPossibility of metastasisLower gastrointestinal tractThyroid follicular adenomaAutopsy seriesMetastatic diseaseSurgical seriesInitial presentationRecipient tumorClinical manifestationsHistopathologic characteristicsThyroid involvementAdenocarcinoma metastaticImmunohistochemical profileColonic adenocarcinomaDifferential diagnosisNecropsy findingsGastrointestinal tractThyroid tumors
2002
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. Journal Of Clinical Investigation 2002, 109: 1321-1326. PMID: 12021247, PMCID: PMC150979, DOI: 10.1172/jci14955.Peer-Reviewed Original ResearchConceptsAspirin treatmentInsulin resistanceTolerance testPlasma glucoseInsulin-stimulated peripheral glucose uptakeHigh-dose aspirin treatmentMixed meal tolerance testType 2 diabetic subjectsMixed-meal tolerance testType 2 diabetes mellitusHigh-dose aspirinWeeks of treatmentC-reactive proteinPeripheral glucose uptakeHyperinsulinemic-euglycemic clampType 2 diabetesPlasma insulin concentrationHepatic glucose productionFatty acid levelsDiabetes mellitusDiabetic subjectsTotal cholesterolGlucose toleranceInsulin clearanceTissue inflammationThe Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes
Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF. The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes. Diabetes 2002, 51: 797-802. PMID: 11872682, PMCID: PMC2995527, DOI: 10.2337/diabetes.51.3.797.Peer-Reviewed Original ResearchMeSH KeywordsAdipocytesAdipose TissueBlood GlucoseBody CompositionCalorimetry, IndirectDiabetes Mellitus, Type 2Fatty AcidsGlucose Clamp TechniqueGlycated HemoglobinGlycerolHumansHyperinsulinismInsulinKineticsLipidsLipolysisLiverMagnetic Resonance SpectroscopyMicrodialysisMiddle AgedMuscle, SkeletalOxidation-ReductionRosiglitazoneThiazolesThiazolidinedionesTriglyceridesConceptsPlasma fatty acid concentrationsMuscle triglyceride contentEffects of rosiglitazoneType 2 diabetesInsulin sensitivityPeripheral adipocytesTriglyceride contentRosiglitazone treatmentFatty acid concentrationsTwo-step hyperinsulinemic-euglycemic clampSkeletal muscle triglyceride contentType 2 diabetic subjectsInsulin-stimulated glucose metabolismWhole-body insulin sensitivityExtramyocellular lipid contentInsulin-responsive organHepatic triglyceride contentHyperinsulinemic-euglycemic clampAdipocyte insulin sensitivityDiabetic subjectsInsulin clampGlucose metabolismGlycerol releaseResponsive organSubcutaneous fatType 2 diabetes therapy
Mayerson AB, Inzucchi SE. Type 2 diabetes therapy. Postgraduate Medicine 2002, 111: 83-95. PMID: 11912999, DOI: 10.3810/pgm.2002.03.1140.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
Academic Achievements & Community Involvement
News
News
- February 18, 2025
Voluntary Faculty Awards Honor Outstanding Educators
- February 14, 2024
Yale Faculty Honored at Inaugural Voluntary Faculty Awards
- October 03, 2022
Voluntary Faculty Contributions to Department of Internal Medicine